|
|
|
Volumn 26, Issue 3 SUPPL. 10, 1999, Pages 3-7
|
|
Emerging role of docetaxel (Taxotere) in advanced non-small cell lung cancer
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFECTIVE AGENT;
DOCETAXEL;
GEMCITABINE;
NAVELBINE;
PACLITAXEL;
PLATINUM;
ADULT;
AGED;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG EFFICACY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG NON SMALL CELL CANCER;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
NEUTROPENIA;
PRIORITY JOURNAL;
REVIEW;
SURVIVAL RATE;
SURVIVAL TIME;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
CARBOPLATIN;
CARCINOMA, NON-SMALL-CELL LUNG;
CISPLATIN;
CLINICAL TRIALS;
HUMANS;
LUNG NEOPLASMS;
PACLITAXEL;
TAXOIDS;
TREATMENT FAILURE;
|
|
EID: 0032771867
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (9)
|
|
References (27)
|
